The Market Reports

Index

1 Antidiabetics Market Overview
1.1 Product Overview and Scope of Antidiabetics
1.2 Antidiabetics Segment by Type
1.2.1 Global Antidiabetics Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Type 1 Diabetes
1.2.3 Type 2 Diabetes
1.2.4 Other
1.3 Antidiabetics Segment by Application
1.3.1 Global Antidiabetics Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Global Antidiabetics Market Size Estimates and Forecasts
1.4.1 Global Antidiabetics Revenue 2016-2027
1.4.2 Global Antidiabetics Sales 2016-2027
1.4.3 Antidiabetics Market Size by Region: 2016 Versus 2021 Versus 2027

2 Antidiabetics Market Competition by Manufacturers
2.1 Global Antidiabetics Sales Market Share by Manufacturers (2016-2021)
2.2 Global Antidiabetics Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antidiabetics Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antidiabetics Manufacturing Sites, Area Served, Product Type
2.5 Antidiabetics Market Competitive Situation and Trends
2.5.1 Antidiabetics Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antidiabetics Players Market Share by Revenue
2.5.3 Global Antidiabetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Antidiabetics Retrospective Market Scenario by Region
3.1 Global Antidiabetics Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Antidiabetics Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Antidiabetics Market Facts & Figures by Country
3.3.1 North America Antidiabetics Sales by Country
3.3.2 North America Antidiabetics Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antidiabetics Market Facts & Figures by Country
3.4.1 Europe Antidiabetics Sales by Country
3.4.2 Europe Antidiabetics Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antidiabetics Market Facts & Figures by Region
3.5.1 Asia Pacific Antidiabetics Sales by Region
3.5.2 Asia Pacific Antidiabetics Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antidiabetics Market Facts & Figures by Country
3.6.1 Latin America Antidiabetics Sales by Country
3.6.2 Latin America Antidiabetics Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Antidiabetics Market Facts & Figures by Country
3.7.1 Middle East and Africa Antidiabetics Sales by Country
3.7.2 Middle East and Africa Antidiabetics Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antidiabetics Historic Market Analysis by Type
4.1 Global Antidiabetics Sales Market Share by Type (2016-2021)
4.2 Global Antidiabetics Revenue Market Share by Type (2016-2021)
4.3 Global Antidiabetics Price by Type (2016-2021)

5 Global Antidiabetics Historic Market Analysis by Application
5.1 Global Antidiabetics Sales Market Share by Application (2016-2021)
5.2 Global Antidiabetics Revenue Market Share by Application (2016-2021)
5.3 Global Antidiabetics Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Sanofi-Aventis
6.1.1 Sanofi-Aventis Corporation Information
6.1.2 Sanofi-Aventis Description and Business Overview
6.1.3 Sanofi-Aventis Antidiabetics Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi-Aventis Antidiabetics Product Portfolio
6.1.5 Sanofi-Aventis Recent Developments/Updates
6.2 Takeda Pharmaceuticals
6.2.1 Takeda Pharmaceuticals Corporation Information
6.2.2 Takeda Pharmaceuticals Description and Business Overview
6.2.3 Takeda Pharmaceuticals Antidiabetics Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Takeda Pharmaceuticals Antidiabetics Product Portfolio
6.2.5 Takeda Pharmaceuticals Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Antidiabetics Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Eli Lilly Antidiabetics Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 Oramed Pharmaceuticals
6.4.1 Oramed Pharmaceuticals Corporation Information
6.4.2 Oramed Pharmaceuticals Description and Business Overview
6.4.3 Oramed Pharmaceuticals Antidiabetics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Oramed Pharmaceuticals Antidiabetics Product Portfolio
6.4.5 Oramed Pharmaceuticals Recent Developments/Updates
6.5 Boehringer Ingelheim
6.5.1 Boehringer Ingelheim Corporation Information
6.5.2 Boehringer Ingelheim Description and Business Overview
6.5.3 Boehringer Ingelheim Antidiabetics Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Boehringer Ingelheim Antidiabetics Product Portfolio
6.5.5 Boehringer Ingelheim Recent Developments/Updates
6.6 Merck & Co. Inc.
6.6.1 Merck & Co. Inc. Corporation Information
6.6.2 Merck & Co. Inc. Description and Business Overview
6.6.3 Merck & Co. Inc. Antidiabetics Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Merck & Co. Inc. Antidiabetics Product Portfolio
6.6.5 Merck & Co. Inc. Recent Developments/Updates
6.7 Novo Nordisk
6.6.1 Novo Nordisk Corporation Information
6.6.2 Novo Nordisk Description and Business Overview
6.6.3 Novo Nordisk Antidiabetics Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novo Nordisk Antidiabetics Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Bristol-Myers Squibb
6.8.1 Bristol-Myers Squibb Corporation Information
6.8.2 Bristol-Myers Squibb Description and Business Overview
6.8.3 Bristol-Myers Squibb Antidiabetics Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bristol-Myers Squibb Antidiabetics Product Portfolio
6.8.5 Bristol-Myers Squibb Recent Developments/Updates
6.9 Halozyme Therapeutics
6.9.1 Halozyme Therapeutics Corporation Information
6.9.2 Halozyme Therapeutics Description and Business Overview
6.9.3 Halozyme Therapeutics Antidiabetics Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Halozyme Therapeutics Antidiabetics Product Portfolio
6.9.5 Halozyme Therapeutics Recent Developments/Updates
6.10 Pfizer
6.10.1 Pfizer Corporation Information
6.10.2 Pfizer Description and Business Overview
6.10.3 Pfizer Antidiabetics Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Pfizer Antidiabetics Product Portfolio
6.10.5 Pfizer Recent Developments/Updates

7 Antidiabetics Manufacturing Cost Analysis
7.1 Antidiabetics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antidiabetics
7.4 Antidiabetics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antidiabetics Distributors List
8.3 Antidiabetics Customers

9 Antidiabetics Market Dynamics
9.1 Antidiabetics Industry Trends
9.2 Antidiabetics Growth Drivers
9.3 Antidiabetics Market Challenges
9.4 Antidiabetics Market Restraints

10 Global Market Forecast
10.1 Antidiabetics Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antidiabetics by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Antidiabetics by Type (2022-2027)
10.2 Antidiabetics Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antidiabetics by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Antidiabetics by Application (2022-2027)
10.3 Antidiabetics Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antidiabetics by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Antidiabetics by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Antidiabetics Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Antidiabetics Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Antidiabetics Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Antidiabetics Covered in This Study
Table 5. Global Antidiabetics Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Antidiabetics Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Antidiabetics Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Antidiabetics Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Antidiabetics Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Antidiabetics Manufacturing Sites and Area Served
Table 11. Manufacturers Antidiabetics Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antidiabetics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antidiabetics as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antidiabetics Sales by Region (2016-2021) & (K Units)
Table 16. Global Antidiabetics Sales Market Share by Region (2016-2021)
Table 17. Global Antidiabetics Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Antidiabetics Sales by Country (2016-2021) & (K Units)
Table 19. North America Antidiabetics Sales Market Share by Country (2016-2021)
Table 20. North America Antidiabetics Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Antidiabetics Revenue Market Share by Country (2016-2021)
Table 22. Europe Antidiabetics Sales by Country (2016-2021) & (K Units)
Table 23. Europe Antidiabetics Sales Market Share by Country (2016-2021)
Table 24. Europe Antidiabetics Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Antidiabetics Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Antidiabetics Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Antidiabetics Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Antidiabetics Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Antidiabetics Revenue Market Share by Region (2016-2021)
Table 30. Latin America Antidiabetics Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Antidiabetics Sales Market Share by Country (2016-2021)
Table 32. Latin America Antidiabetics Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Antidiabetics Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Antidiabetics Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Antidiabetics Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Antidiabetics Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Antidiabetics Revenue Market Share by Country (2016-2021)
Table 38. Global Antidiabetics Sales (K Units) by Type (2016-2021)
Table 39. Global Antidiabetics Sales Market Share by Type (2016-2021)
Table 40. Global Antidiabetics Revenue (Million US$) by Type (2016-2021)
Table 41. Global Antidiabetics Revenue Share by Type (2016-2021)
Table 42. Global Antidiabetics Price (USD/Unit) by Type (2016-2021)
Table 43. Global Antidiabetics Sales (K Units) by Application (2016-2021)
Table 44. Global Antidiabetics Sales Market Share by Application (2016-2021)
Table 45. Global Antidiabetics Revenue (Million US$) by Application (2016-2021)
Table 46. Global Antidiabetics Revenue Share by Application (2016-2021)
Table 47. Global Antidiabetics Price (USD/Unit) by Application (2016-2021)
Table 48. Sanofi-Aventis Corporation Information
Table 49. Sanofi-Aventis Description and Business Overview
Table 50. Sanofi-Aventis Antidiabetics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Sanofi-Aventis Antidiabetics Product
Table 52. Sanofi-Aventis Recent Developments/Updates
Table 53. Takeda Pharmaceuticals Corporation Information
Table 54. Takeda Pharmaceuticals Description and Business Overview
Table 55. Takeda Pharmaceuticals Antidiabetics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Takeda Pharmaceuticals Antidiabetics Product
Table 57. Takeda Pharmaceuticals Recent Developments/Updates
Table 58. Eli Lilly Corporation Information
Table 59. Eli Lilly Description and Business Overview
Table 60. Eli Lilly Antidiabetics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Eli Lilly Antidiabetics Product
Table 62. Eli Lilly Recent Developments/Updates
Table 63. Oramed Pharmaceuticals Corporation Information
Table 64. Oramed Pharmaceuticals Description and Business Overview
Table 65. Oramed Pharmaceuticals Antidiabetics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Oramed Pharmaceuticals Antidiabetics Product
Table 67. Oramed Pharmaceuticals Recent Developments/Updates
Table 68. Boehringer Ingelheim Corporation Information
Table 69. Boehringer Ingelheim Description and Business Overview
Table 70. Boehringer Ingelheim Antidiabetics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Boehringer Ingelheim Antidiabetics Product
Table 72. Boehringer Ingelheim Recent Developments/Updates
Table 73. Merck & Co. Inc. Corporation Information
Table 74. Merck & Co. Inc. Description and Business Overview
Table 75. Merck & Co. Inc. Antidiabetics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Merck & Co. Inc. Antidiabetics Product
Table 77. Merck & Co. Inc. Recent Developments/Updates
Table 78. Novo Nordisk Corporation Information
Table 79. Novo Nordisk Description and Business Overview
Table 80. Novo Nordisk Antidiabetics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Novo Nordisk Antidiabetics Product
Table 82. Novo Nordisk Recent Developments/Updates
Table 83. Bristol-Myers Squibb Corporation Information
Table 84. Bristol-Myers Squibb Description and Business Overview
Table 85. Bristol-Myers Squibb Antidiabetics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Bristol-Myers Squibb Antidiabetics Product
Table 87. Bristol-Myers Squibb Recent Developments/Updates
Table 88. Halozyme Therapeutics Corporation Information
Table 89. Halozyme Therapeutics Description and Business Overview
Table 90. Halozyme Therapeutics Antidiabetics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Halozyme Therapeutics Antidiabetics Product
Table 92. Halozyme Therapeutics Recent Developments/Updates
Table 93. Pfizer Corporation Information
Table 94. Pfizer Description and Business Overview
Table 95. Pfizer Antidiabetics Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Pfizer Antidiabetics Product
Table 97. Pfizer Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Antidiabetics Distributors List
Table 101. Antidiabetics Customers List
Table 102. Antidiabetics Market Trends
Table 103. Antidiabetics Growth Drivers
Table 104. Antidiabetics Market Challenges
Table 105. Antidiabetics Market Restraints
Table 106. Global Antidiabetics Sales Forecast by Type (2022-2027) & (K Units)
Table 107. Global Antidiabetics Sales Market Share Forecast by Type (2022-2027)
Table 108. Global Antidiabetics Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 109. Global Antidiabetics Revenue Market Share Forecast by Type (2022-2027)
Table 110. Global Antidiabetics Sales Forecast by Application (2022-2027) & (K Units)
Table 111. Global Antidiabetics Sales Market Share Forecast by Application (2022-2027)
Table 112. Global Antidiabetics Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 113. Global Antidiabetics Revenue Market Share Forecast by Application (2022-2027)
Table 114. Global Antidiabetics Sales Forecast by Region (2022-2027) & (K Units)
Table 115. Global Antidiabetics Sales Market Share Forecast by Region (2022-2027)
Table 116. Global Antidiabetics Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 117. Global Antidiabetics Revenue Market Share Forecast by Region (2022-2027)
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Antidiabetics
Figure 2. Global Antidiabetics Market Share by Type in 2020 & 2027
Figure 3. Type 1 Diabetes Product Picture
Figure 4. Type 2 Diabetes Product Picture
Figure 5. Other Product Picture
Figure 6. Global Antidiabetics Market Share by Application in 2020 & 2027
Figure 7. Hospital Use
Figure 8. Clinic Use
Figure 9. Household
Figure 10. Other
Figure 11. Global Antidiabetics Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Antidiabetics Market Size 2016-2027 (US$ Million)
Figure 13. Global Antidiabetics Sales 2016-2027 (K Units)
Figure 14. Global Antidiabetics Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Antidiabetics Sales Share by Manufacturers in 2020
Figure 16. Global Antidiabetics Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Antidiabetics Players: Market Share by Revenue in 2020
Figure 18. Antidiabetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Antidiabetics Sales Market Share by Region (2016-2021)
Figure 20. Global Antidiabetics Sales Market Share by Region in 2020
Figure 21. Global Antidiabetics Revenue Market Share by Region (2016-2021)
Figure 22. Global Antidiabetics Revenue Market Share by Region in 2020
Figure 23. U.S. Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Antidiabetics Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Antidiabetics by Type (2016-2021)
Figure 48. Sales Market Share of Antidiabetics by Application (2016-2021)
Figure 49. Sales Market Share of Antidiabetics by Application in 2020
Figure 50. Revenue Share of Antidiabetics by Application (2016-2021)
Figure 51. Revenue Share of Antidiabetics by Application in 2020
Figure 52. Manufacturing Cost Structure of Antidiabetics
Figure 53. Manufacturing Process Analysis of Antidiabetics
Figure 54. Antidiabetics Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed